Schedule 13G ownership disclosure

AERIE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00771V108

Event date: 2016-02-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
844,240
Percent of class
3.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-16-083417
Form type
SC 13G
Filer
AERIE PHARMACEUTICALS INC
CIK
CIK 1337553
Filed
Feb 19, 2016
Reporting period
Feb 09, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub